PIP-AMITRIPTYLINE amitriptyline hydrochloride 50mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

amitriptyline hydrochloride, Quantity: 50 mg

Disponibbli minn:

Ipca Pharma (Australia) Pty Ltd

INN (Isem Internazzjonali):

amitriptyline hydrochloride

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: purified talc; hypromellose; macrogol 6000; sunset yellow FCF aluminium lake; microcrystalline cellulose; lactose monohydrate; titanium dioxide; crospovidone; maize starch; magnesium stearate; colloidal anhydrous silica; indigo carmine aluminium lake

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

20, 50 and 100

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Sommarju tal-prodott:

Visual Identification: Brown colour, circular, biconvex, film coated tablets with 'IA' over '50' debossed on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-08-22